Tranche Update on Novo Nordisk A/S (CPSE:NOVO B)'s Equity Buyback Plan announced on January 31, 2024.

From January 31, 2024 to April 30, 2024, the company has repurchased 2,423,000 shares, representing 0.05% for DKK 2,100 million. With this, the company has completed the repurchase of 2,423,000 shares, representing 0.05% for DKK 2,100 million under the buyback announced on January 31, 2024.